Notably, pathways related to cancer, such as MF: cytokine binding and KEGG: Cell adhesion molecules, suggested that the downregulation of PCTK1 and upregulation of BMPR1B may influence cancer cell proliferation and drug sensitivity through mechanisms associated with cell adhesion molecules. Here, CDK16 is linked to cancer.